We are live on ! Find out more
WIA

Wealthstreet Investment Advisors Portfolio holdings

AUM $3.71M
1-Year Est. Return 13.1%
This Fund
S&P 500
This Quarter Est. Return
+12.13%
1 Year Est. Return
+13.1%
3 Year Est. Return
+75.79%
5 Year Est. Return
10 Year Est. Return
AUM
$857M
AUM Growth
+$74.4M
Cap. Flow
+$16.5M
Cap. Flow %
1.93%
Top 10 Hldgs %
25.43%
Holding
353
New
18
Increased
76
Reduced
99
Closed
3

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$14.8M
2
UNH icon
UnitedHealth
UNH
+$661K
3
CVX icon
Chevron
CVX
+$653K
4
NTNX icon
Nutanix
NTNX
+$554K
5
LLY icon
Eli Lilly
LLY
+$545K

Sector Composition

Rank Sector Weight
1 Healthcare 18.24%
2 Technology 15.78%
3 Financials 11.55%
4 Industrials 10.57%
5 Consumer Staples 9.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCL icon
201
Carnival Corporation Ltd
CCL
$35B
$684K 0.08%
13,460
FNDF icon
202
Schwab Fundamental International Large Company Index ETF
FNDF
$26.1B
$683K 0.08%
23,620
+500
+2% +$14.2K
MMM icon
203
3M
MMM
$92.8B
$674K 0.08%
4,564
-654
-13% -$91.6K
IEO icon
204
iShares US Oil & Gas Exploration & Production ETF
IEO
$610M
$668K 0.08%
12,030
-666
-5% -$34.5K
WBA
205
DELISTED
Walgreens Boots Alliance
WBA
$667K 0.08%
11,323
KHC icon
206
Kraft Heinz
KHC
$29.4B
$652K 0.08%
20,293
-869
-4% -$26.3K
PXD
207
DELISTED
Pioneer Natural Resource Co.
PXD
$647K 0.08%
4,275
SCHA icon
208
Schwab U.S Small- Cap ETF
SCHA
$23B
$645K 0.08%
34,100
+960
+3% +$17.4K
WDC icon
209
Western Digital
WDC
$169B
$642K 0.07%
13,379
-530
-4% -$22.1K
BMRN icon
210
BioMarin Pharmaceuticals
BMRN
$12.7B
$623K 0.07%
7,373
-2,000
-21% -$151K
ETN icon
211
Eaton
ETN
$163B
$616K 0.07%
6,501
IWM icon
212
iShares Russell 2000 ETF
IWM
$81.6B
$608K 0.07%
3,668
+770
+27% +$122K
ORCL icon
213
Oracle
ORCL
$429B
$606K 0.07%
11,444
K
214
DELISTED
Kellanova
K
$600K 0.07%
9,239
GEN icon
215
Gen Digital
GEN
$17.7B
$595K 0.07%
23,332
AIG icon
216
American International
AIG
$40.2B
$591K 0.07%
11,508
TEL icon
217
TE Connectivity
TEL
$59.4B
$587K 0.07%
6,128
HOLX
218
DELISTED
Hologic
HOLX
$585K 0.07%
11,200
DES icon
219
WisdomTree US SmallCap Dividend Fund
DES
$2.21B
$574K 0.07%
+20,012
New +$558K
SPMO icon
220
Invesco S&P 500 Momentum ETF
SPMO
$21.9B
$574K 0.07%
13,700
-50
-0.4% -$2.04K
DAL icon
221
Delta Air Lines
DAL
$54.6B
$569K 0.07%
9,733
+108
+1% +$6.06K
IFLN
222
Invesco Bloomberg Enhanced Fallen Angels ETF
IFLN
$306M
$567K 0.07%
29,450
VFH icon
223
Vanguard Financials ETF
VFH
$13.9B
$560K 0.07%
7,340
TDOC icon
224
Teladoc Health
TDOC
$1.15B
$557K 0.07%
6,652
AEP icon
225
American Electric Power
AEP
$67.2B
$555K 0.06%
5,876

Similar funds

Wealthstreet Investment Advisors's Q4 2019 Portfolio in Review

As of Q4 2019, Wealthstreet Investment Advisors held 353 positions worth $857M, up 9.5% from $783M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Wealthstreet Investment Advisors's Q4 2019 filing shows 18 new, 76 increased, 99 reduced and 3 closed positions. Its largest new stake was WisdomTree US SmallCap Dividend Fund: 20,012 shares worth $574K. The largest sale was Celgene Corp, an estimated $14.8M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 19% a quarter earlier, followed by Technology and Financials.

  • Wealthstreet Investment Advisors's largest Q4 2019 buy was WisdomTree US SmallCap Dividend Fund: 20,012 shares worth $574K.
  • Wealthstreet Investment Advisors added most to Bristol-Myers Squibb in Q4 2019, an estimated $8.44M increase.
  • Wealthstreet Investment Advisors's biggest Q4 2019 reduction was UnitedHealth, cutting an estimated $661K.
  • Wealthstreet Investment Advisors fully exited Celgene Corp in Q4 2019, selling an estimated $14.8M.
  • Wealthstreet Investment Advisors's ten largest holdings make up 25% of its $857M portfolio in Q4 2019.
  • Wealthstreet Investment Advisors opened 18 new positions and closed 3 in Q4 2019.
  • Wealthstreet Investment Advisors's portfolio value rose 9.5% quarter-over-quarter to $857M.

Based on Wealthstreet Investment Advisors's 13F filing for Q4 2019, filed 22 Jan 2020.